Treatment with Tumor-Treating Fields Therapy and Pulse Dose Bevacizumab in Patients with Bevacizumab-Refractory Recurrent Glioblastoma: A Case Series

Publisher： Karger

E-ISSN： 1662-680x|8|1|1-9

ISSN： 1662-680x

Source： Case Reports in Neurology, Vol.8, Iss.1, 2016-01, pp. : 1-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Resolution of Cystic Enhancement to Add-On Tumor Treating Electric Fields for Recurrent Glioblastoma after Incomplete Response to Bevacizumab

By  

Case Reports in Neurology, Vol. 6, Iss. 1, 2014-04 ,pp. : 109-115

Karger

Access to resources Recommend Favorite

A change in the apparent diffusion coefficient after treatment with bevacizumab is associated with decreased survival in patients with recurrent glioblastoma multiforme

By PALDINO M J   DESJARDINS A   FRIEDMAN H S   VREDENBURGH J J   BARBORIAK D P  

British Journal of Radiology, Vol. 85, Iss. 1012, 2012-04 ,pp. : 382-389

British Institute of Radiology

Access to resources Recommend Favorite

A Case of Long Partial Response to Combination Therapy of Bevacizumab and Capecitabine for Liver Metastases of Rectal Cancer

By  

Case Reports in Gastroenterology, Vol. 5, Iss. 1, 2011-01 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping

By  

Medical Principles and Practice, Vol. 23, Iss. 5, 2014-03 ,pp. : 478-481

Karger

Access to resources Recommend Favorite

Treatment of Pediatric Refractory Coccidioidomycosis With Combination Voriconazole and Caspofungin: A Retrospective Case Series

By Levy Emily R.   McCarty James M.   Shane Andi L.   Weintrub Peggy S.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1573-1578

Oxford University Press

Access to resources Recommend Favorite